Wei Wang

Wei Wang

Auto-generated profile, based on publicly available information

Wei Wang

Department of Cardiac Surgery, China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in International Journal of Surgery
Verified
Journal Article
Open access
KYKang Yi
Kang Yi
WWWei Wang
Wei Wang
JXJianguo Xu
Jianguo Xu
XZXin Zhang
Xin Zhang
WWWenxin Wang
Wenxin Wang
TYTao You
Tao You
Background: Uncertainties persist about whether to aggressively and effectively treat tricuspid regurgitation (TR) during mitral valve (MV) surgery. Review methods: Systematic literature searches were performed in five databases to collect all relevant studies published before May 2022 on whether the tricuspid valve (TV) was treated during MV surgery. Separate meta-analyses were performed on data from Unmatched studies and Randomized controlled trials (RCT)/Adjusted studies. Main Results: A total of 44 publications were included, of which eight were RCT studies and the rest were retrospective studies. There was no difference in 30-day mortality [odds ratio (OR): 1.00, 95% confidence interval (95%CI): 0.71–1.42, OR: 0.66, 95%CI: 0.30–1.41)] or overall survival [hazard ratio (HR): 1.01, 95%CI: 0.85–1.19, HR: 0.77, 95%CI: 0.52–1.14] in Unmatched studies and RCT/Adjusted studies. Late mortality (OR: 0.37, 95%CI: 0.21-0.64) and cardiac-related mortality (OR: 0.36, 95%CI: 0.21–0.62) were lower in the TV repair (TVR) group in the RCT/Adjusted studies. In the Unmatched studies, overall cardiac mortality (OR: 0.48, 95%CI: 0.26–0.88) was lower in the TVR group. In the late TR progression analysis, the late TR progression was lower among patients in the concomitantly intervened tricuspid group, and patients in the untreated tricuspid group were prone to TR progression in both studies (HR: 0.30, 95%CI: 0.22–0.41, HR: 0.37, 95%CI: 0.23–0.58). Conclusions: TVR concomitant with MV surgery is most effective in patients with significant TR and dilated tricuspid annulus, especially those with a significantly reduced risk of distant TR progression. Systematic Review Registration: PROSPERO, identifier: CRD42022380967.

30 January 2025 in International Journal of Surgery
Verified
Journal Article
Open access
WWWei Wang
Wei Wang
RTRui Tang
Rui Tang
TGTianxiang Gu
Tianxiang Gu
ESEnyi Shi
Enyi Shi
An abstract is unavailable. This article is available as a PDF only.